Header
For Healthcare Professionals

Is Trajenta (linagliptin) contraindicated in renal failure?

J.M Co, Prof Cooper

J.M Co, Prof Cooper

i) Not all DPP4i are the same with the patients have reduced eGFR.
ii) Linagliptin is the one drug that does not need to alter the dose
iii) others need to reduce dose. Many doctors forget

Related content

What do you think of the safety profile of the DPP4-inhibitors.png
J.M Co, Prof Cooper

What do you think of the safety profile of the DPP4-inhibitors?

  • 1.1.2023
is dpp4i suitable for admitted patients.png
J.M Co, Prof Cooper

Is DPP4i suitable for admitted patients?

  • 1.1.2023
What are the evidence of Trajenta (Linagliptin) in patients with type 2 dia.png.png
J.M Co, Prof Cooper

What are the evidence of  Trajenta (Linagliptin) in patients with type 2 diabetes and across different kidney profile or renal dysfunction?

  • 1.1.2023